Zymenex

Biotechnology Research · 11 Employees
Phone Number: 4548250054
Email Address: zxmail@zymenex.com
  • Overview
  • Employees
Access 5 Verified Employees Profiles for ZymenexUnlock Free Contacts Now
About
Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. Zymenex is developing several human recombinant enzymes that can be used for therapy within specific disease areas. The products are expected to be able to help patients, who today have serious handicaps, reduced quality of life and a markedly reduced life expectancy. Enzyme replacement therapy is a well-known treatment method and there are a number of products on the market today that validates the company concept. The company’s Research and Development focuses on Lysosomal Storage Diseases, which is a common name for human diseases, where the ability of the human body to break down specific molecules in the lysosomes in the cells is reduced or impaired. The diseases most often affect children, they are lethal and there is no therapy available today.
Year Founded
1998
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Roskildevej 12C Hillerod, Capital Region 3400, DK
Keywords
Zymenex is engaged in the research and development of innovative therapeutics for life threatening diseases.
Location
  • Roskildevej 12C Hillerod, Capital Region 3400, DK

Email Formats

Sign up for free credits and discover verified email addresses of Zymenex
FormatExamples
first + last
andywarhol@zymenex.com
first_initial + last
awarhol@zymenex.com
first + last_initial
andyw@zymenex.com
first
andy@zymenex.com
last
warhol@zymenex.com
Get Verified Emails for 5 Zymenex Employees

Frequently Asked Questions

Learn More about Zymenex
Key Contacts

Similar Companies

Biotechnology Research

Get key business info for Zymenex and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.